Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness

Cholangiocarcinoma (CCA) is the second most common primary liver malignancy with extremely poor therapeutic outcome due to high drug resistance, widespread metastasis and lack of effective treatment options. CCA progression and metastasis are regulated by multiple biological factors including multip...

Full description

Saved in:
Bibliographic Details
Published in:Theranostics
Main Authors: Xie, Ying, Wang, Yazhe, Li, Jing, Hang, Yu, Jaramillo, Lee, Wehrkamp, Cody J., Phillippi, Mary Anne, Mohr, Ashley M., Chen, Yi, Talmon, Geoffrey A., Mott, Justin L., Oupický, David
Format: Artigo
Language:Inglês
Published: Ivyspring International Publisher 2018
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134930/
https://ncbi.nlm.nih.gov/pubmed/30214622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.26506
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items